Back to Journals » OncoTargets and Therapy » Volume 10

MicroRNA 543 suppresses breast cancer cell proliferation, blocks cell cycle and induces cell apoptosis via direct targeting of ERK/MAPK

Authors Chen P, Xu W, Luo Y, Zhang Y, He Y, Yang S, Yuan Z

Received 28 July 2016

Accepted for publication 12 December 2016

Published 6 March 2017 Volume 2017:10 Pages 1423—1431

DOI https://doi.org/10.2147/OTT.S118366

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Amy Norman

Peer reviewer comments 6

Editor who approved publication: Dr Jianmin Xu

Po Chen,1 Wentao Xu,2 Yi Luo,1 Yi Zhang,3 Yi He,1 Shuo Yang,1 Zhijun Yuan1

1Department of Medical Oncology, Hunan Cancer Hospital, Changsha, 2Clinical Medical College of An Hui Medical University, Hefei, 3Department of Breast Surgery, Hunan Cancer Hospital, Changsha, China


Background:
Breast cancer affects millions of people with a high mortality rate throughout the world; microRNA 543 (miR-543) has been reported to suppress progression in some kinds of cancers, but has not been reported in breast cancer. Thus, the purpose of this study is to investigate the function of miR-543 in breast cancer cells.
Methods: Two cell lines, MCF-7 and MDA-MB-231, were selected to be the research objects; the miR-543 overexpression and knockdown models were established in the study by transforming miR-543 mimics and miR-543 inhibitor. Real-time polymerase chain reaction, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Western blot, clone formation and cell flow cytometer assay were used to test the miR-543’s function. Dual-luciferase assay was used for the detection of miR-543 and ERK2 targeting relationship.
Results: The results showed that the cell proliferation and cell cycle were inhibited, and the capability of cell apoptosis was upregulated when miR-543 was overexpressed; we found that there was a target relationship between ERK2 and miR-543. Furthermore, downstream factors of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase-2 (ERK2) pathway, including RSK2 and MSK1, were decreased in miR-543 overexpression model.
Conclusion: This study provides series evidences to support that breast cancer progression was inhibited by miR-543 via direct targeting of ERK2 in MAPK/ERK signal pathway, which may provide a molecular basis for better treatment for patients.

Keywords: microRNA 543, breast cancer, ERK2, apoptosis, cell cycle, proliferation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]